Medpace
MEDP
592 hedge funds and large institutions have $8.42B invested in Medpace in 2024 Q4 according to their latest regulatory filings, with 100 funds opening new positions, 216 increasing their positions, 210 reducing their positions, and 82 closing their positions.
22% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 82
12% more call options, than puts
Call options by funds: $26.1M | Put options by funds: $23.4M
2% more funds holding
Funds holding: 583 → 592 (+9)
3% more repeat investments, than reductions
Existing positions increased: 216 | Existing positions reduced: 210
0.36% less ownership
Funds ownership: 81.94% → 81.58% (-0.36%)
1% less capital invested
Capital invested by funds: $8.47B → $8.42B (-$43.1M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
Top Sellers
MEDP Hedge Fund Activity: Q4 2024 in Review
592 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2024, worth a combined $8.42B — down 0.51% from $8.47B a quarter earlier.
Buyers outnumbered sellers: 100 funds opened new MEDP positions and 82 closed out — a net gain of 18 holders — while 216 added to existing stakes and 210 trimmed.
The largest buyer was Invesco, adding an estimated $176M. The largest seller was Wellington Management Group, cutting an estimated $128M.
- 592 institutional investors held Medpace (MEDP) as of Q4 2024, up from 583 in Q3 2024.
- Funds reported $8.42B of Medpace stock for Q4 2024, down 0.51% quarter-over-quarter.
- 100 funds opened new Medpace positions in Q4 2024 and 82 closed out, a net change of +18 holders.
- The largest Medpace buyer in Q4 2024 was Invesco, an estimated $176M added.
- The largest Medpace seller in Q4 2024 was Wellington Management Group, an estimated $128M sold.
Based on aggregated 13F filings for Q4 2024.